| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $109.2M | — | +0.0% |
| R&D Expense | $17.1M | — | -35.6% |
| SG&A Expense | $6.6M | — | -21.8% |
| Operating Income | -$23.7M | — | -131.9% |
| Net Income | -$21.6M | — | -128.3% |
| EPS (Basic) | -$0.11 | — | -112.4% |
| EPS (Diluted) | -$0.11 | — | -112.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $51.0M | -17.5% | -1.6% |
| Short-term Investments | $83.8M | +51.6% | -26.0% |
| Current Assets | $139.0M | +15.1% | -18.0% |
| Total Assets | $326.6M | +46.0% | +3.5% |
| Current Liabilities | $13.6M | -32.9% | -6.5% |
| Total Liabilities | $61.8M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$25.3M | — | +27.0% |
| Capital Expenditures | $584K | — | +22.9% |
| Investing Cash Flow | -$112.6M | — | -503.2% |
| Financing Cash Flow | $126.6M | — | — |
| Free Cash Flow | -$25.8M | — | +26.4% |
| -17.8% |
| Stockholders' Equity | $264.7M | +66.6% | +10.1% |